High-quality data is increasingly central to drug discovery, yet much of it remains fragmented, difficult to interpret, and hard to translate into clear R&D decisions. Ruchi Sharma, CEO of Stemnovate, shares how the company has navigated data complexity across human and animal health to build reproducible, species-relevant models that support more informed drug discovery decisions.























